Annals of Surgical Oncology

, Volume 20, Issue 2, pp 627–632 | Cite as

When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections

  • Windy Olaya
  • Jasmine Wong
  • Jan Wong
  • John Morgan
  • Kevork Kazanjian
  • Sharon LumEmail author
Breast Oncology



We sought to compare the number of lymph nodes (LN) resected in axillary lymph node dissections (ALND) and sentinel lymph node dissections (SLND), and to assess the validity of registry reporting for axillary staging in breast cancer.


Women in the California Cancer Registry who underwent surgical axillary staging for T1/T2, M0 breast cancer between 2004 and 2008 were evaluated. The number of LN resected in patients reported as having SLND+ALND and ALND were assessed for compliance with 6 and 10 LN threshold definitions for ALND. The proportion of patients with ≤3 LN removed was assessed for patients receiving SLND only.


Of 71,907 patients, 45.5 % had SLND, 24.0 %, SLND+ALND, and 30.5 %, ALND. The median number of LN resected with SLND cases was 2 (range 1–41); SLND+ALND, 9 (range 1–63); and ALND, 11 (range 1–81) (p < 0.0001). Of patients undergoing ALND, 56.7 % had ≥10 LN removed; 46.2 % of patients with SLND+ALND had ≥10 LN removed (p < 0.0001). Overall, 75.5 % of patients with ALND had ≥6 LN removed and 67.8 % of patients with SLND+ALND had ≥6 LN removed (p < 0.0001). Of those receiving only SLND, 83.4 % had ≤3 LN removed.


A significant proportion of patients did not meet the minimum LN count thresholds for full ALND or had excess LN removed in a SLND. Further investigation is required to determine whether absolute LN number or reported operative procedure and implied surgical technique better defines axillary staging in a registry database.


Sentinel Node Axillary Lymph Node Dissection Lymph Node Count Sentinel Lymph Node Dissection Axillary Staging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Supported in part by NCI/SEER contracts N01-PC-35136, N01-PC-35139, and N02-PC-15105; CDC/National Program for Cancer Registries contract U58DP000807-01; and the California Department of Public Health, Cancer Surveillance Branch.


  1. 1.
    American College of Surgeons. National Accreditation Program for Breast Centers. Breast center standards manual. Accessed 15 Apr 2012.
  2. 2.
    Soper NJ, Kaufman DB, eds. Northwestern handbook of surgical procedures. 2nd ed. Austin, TX: Landes Bioscience, 2011.Google Scholar
  3. 3.
    Zollinger RMJ, Zollinger RM. Atlas of surgical operations. New York: MacGraw-Hill, 1993.Google Scholar
  4. 4.
    Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28A:1415–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 305:569–75.Google Scholar
  6. 6.
    Krag DN. Training manual for NSABP B-32. Pittsburgh, 1999.Google Scholar
  7. 7.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–9.PubMedCrossRefGoogle Scholar
  10. 10.
    McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–6.PubMedGoogle Scholar
  11. 11.
    American Society of Breast Surgeons. Guidelines for performing sentinel lymph node biopsy in breast cancer. Accessed 15 Apr 2012.
  12. 12.
    Chagpar AB, Scoggins CR, Martin RC 2nd, et al. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007;13:233–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Olaya W, Wong J, Morgan JW, et al. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010;17(3):297–302.PubMedCrossRefGoogle Scholar
  14. 14.
    Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008;113:30–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Zakaria S, Degnim AC, Kleer CG, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96:554–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Cil T, Hauspy J, Kahn H, et al. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Ann Surg Oncol. 2008;15:3361–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242:593–9.PubMedGoogle Scholar
  19. 19.
    American College of Surgeons. Coding cancer registry items. Scope of regional lymph node surgery: a review of data validity, revised coding directives, and agency transition plans. Accessed 15 Apr 2012.

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • Windy Olaya
    • 1
  • Jasmine Wong
    • 1
  • Jan Wong
    • 2
  • John Morgan
    • 3
    • 4
  • Kevork Kazanjian
    • 1
  • Sharon Lum
    • 1
    • 4
    Email author
  1. 1.Division of Surgical Oncology, Department of SurgeryLoma Linda University School of MedicineLoma LindaUSA
  2. 2.Division of Surgical Oncology, Department of SurgeryBrody School of Medicine, East Carolina UniversityGreenvilleUSA
  3. 3.Loma Linda University School of Public HealthLoma LindaUSA
  4. 4.Desert Sierra Cancer Surveillance Program, California Cancer RegistryLoma Linda UniversityLoma LindaUSA

Personalised recommendations